Journal Guide

new antibiotics

immunology

Antimicrobial Agents and Chemotherapy® features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy. The journal also publishes studies involving animal models, pharmacological characterization, and clinical trials.

Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action;new or improved vaccines against viral infections of humans and animals;assessments of drug and vaccine safety;evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures;identification and validation of new drug targets;laboratory animal models of viral diseases;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.Antiviral Research is an official publication of the International Society for Antiviral Research (http://www.isar-icar.com).Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases (2009 ISI impact factor: 4.32).The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.

Apoptosis is an international peer-reviewed journal devoted to the rapid publication of innovative basic and clinically-oriented investigations into programmed cell death. It aims to stimulate research on the basis of mechanisms of apoptosis and on its role in various human disease processes including: cancer, autoimmune disease, viral infection, AIDS, cardiovascular disease, neurodegenerative disorders, osteoporosis and ageing. The editors intend to encourage the development of clinical therapies against apoptosis-related diseases.

Applied Clinical Research, Clinical Trials and Regulatory Affairs is an international journal with market leadership in readership and contributions that are scientific, original, relevant, innovative and statistically validated. The journal aims to further bridge the gap in the publication of clinical drug development and regulatory affairs between high growth and potentially growing regions.

Applied & Translational Genomics is a new open access biomedical journal providing a forum for publication and discussion of cutting edge research and new developments in applied and translational genomics, including information technologies that enable both advances in the field as well as the application of advances to clinical care and educational, ethical, economic, public health, citizen and policy issues pertinent to research advances. As such the Applied & Translational Genomics is a uniquely interdisciplinary journal. Further, it aims to publish new approaches to 'translational genomics', such as studies designed to probe the elasticity and dynamism of molecular processes. The Journal's mission is to enhance the knowledge, clinical adoption and discussion of applied and translational genomics worldwide. Its ethics mission is to enable global benefit sharing through the publication of articles, analyses and commentaries of researchers, clinicians, and patient populations situated throughout the world. The journal encourages submissions by authors in the developing world and to support their access to publishing, the Journal invites authors for whom processing fees represent a barrier, to contact the editor about our sliding fee scale policy.

Aquatic Toxicology publishes original scientific papers dealing with the mechanisms of toxicity and the responses to toxic agents in aquatic environments at the community, species, tissue, cellular, subcellular and molecular levels, including aspects of uptake, metabolism and excretion of toxicants.The aim of the journal is to increase our understanding of the impact of toxicants on aquatic organisms and ecosystems. Studies with aquatic model systems that provide fundamental mechanistic insight to toxic effects on organisms in general are also welcome. Both laboratory and field studies will be considered. The mechanistic focus includes genetic disturbances and adaptations to environmental perturbations, including the evolution of toxicant responses; biochemical, physiological and behavioural responses of organisms to toxicants; interactions of genetic and functional responses, and interactions between natural and toxicant-induced environmental changes. The bioaccumulation of contaminants is considered when studies address mechanisms influencing accumulation. Ecological investigations that address reasons, possibly also considering their genetic and physiological aspects, for toxicant-induced alterations of aquatic communities or populations are suitable.Reports on technique development or monitoring efforts are generally not within the scope of Aquatic Toxicology, except those concerning new methodologies for mechanistic research with an example of their application. Identification of toxicants or toxicologically relevant molecules in organisms will be considered only if the identification is a part of a more comprehensive mechanistic study. Whenever possible, information of exposure should be based on measured concentrations and not nominal or assumed ones. Manuscripts reporting acute toxicity data (lethal concentration, LC-50 or lethal dose, LD-50) as a major finding are usually not considered.

Archives of Environmental Contamination and Toxicology is a repository of significant, peer-reviewed articles describing original experimental or theoretical research work on the scientific aspects of contaminants in the environment. It provides a place for the publication of detailed, definitive and credible reports concerning advances and discoveries in the fields of air, water, and soil contamination and pollution, human health aspects, and in disciplines concerned with the introduction, presence, and effects of deleterious substances in the total environment. Papers accepted for publication in the Archives deal with aspects of environmental contaminants, including those that lie in the domains of analytical chemistry, biochemistry, pharmacology, toxicology, agricultural, air, water, and soil chemistry. The Editor-in-Chief is Daniel R. Doerge, National Center for Toxicological Research, Paron, AR USA.

Archives of Environmental & Occupational Health , originally founded in 1919 as the Journal of Industrial Hygiene, and perhaps most well-known as the Archives of Environmental Health, reports, integrates, and consolidates the latest research, both nationally and internationally, from fields germane to environmental health, including epidemiology, toxicology, exposure assessment, modeling and biostatistics, risk science and biochemistry. Publishing new research based on the most rigorous methods and discussion to put this work in perspective for public health, public policy, and sustainability, the Archives addresses such topics of current concern as health significance of chemical exposure, toxic waste, new and old energy technologies, industrial processes, and the environmental causation of disease such as neurotoxicity, birth defects, cancer, and chronic degenerative diseases. For more than 90 years, this noted journal has provided objective documentation of the effects of environmental agents on human and, in some cases, animal populations and information of practical importance on which decisions are based.To support diverse communication of scholarly material, the following formats are available: Full-Length Manuscripts should not exceed 24 pages of double-spaced draft text (Times font, 12-point type), regardless of the combination of text, illustrations, and references. Brief Communications. Pithy articles of 1,500 words or less and no more than 2 illustrations will receive expeditious handling. Such communications may include critical analyses of current problems and issues. Case Studies. AEOH will publish occasional longer case studies of relevant environmental and occupational issues of 8-12 printed pages in length (approximately 24–36 pages of double-spaced draft text, Times font, 12-point type).

Archives of Pharmacal Research is an interdisciplinary journal devoted to the publication of original scientific research papers and reviews in the fields of drug discovery, drug development, and drug actions with a view to providing fundamental and novel information on drugs and drug candidates.

Manuscripts will be considered for publication on the condition that the results reported are based on original research that has not been published elsewhere in any journal.

Upon acceptance for publication of an article in Archives of Pharmacal Research, the author tacitly agrees to make available any materials used in the published experiments, or novel or natural products disclosed in the article that are not commercially available, so that other researchers may confirm the observations.

For the studies using natural extract, the journal will determine the acceptability of such papers on an individual basis. Natural product contribution must meet the following specific criteria: a) any n

Archives of Razi Institute Scientific-Research Journal is one of Iran's oldest scientific professional research journals being published annually since 1938 under title: Archive de l'Institut Razi in French language and since 60th decade under title: Archives of Razi Institute in English. Its publication has been continued upto the present under ISSN: 3439-0365. This journal has aquired Scientific-Research degree grade via 153th session of MSRT's Scientific Journals evaluation Comminssion on 2000. Archives of Razi Institute is an outspring of research activities of scientists and researchers working on various sections of Razi Vaccine and Serum Research Institute and other Iranian universities and research centers for more than 85 years covering different fields of veterinary medicine, zoonoses and producing biological products. The addressees of the journal are veterinary and medical students, university professors and other relevant researchers inland and abroad.

Archives of Toxicology provides up-to-date information on the latest advances in toxicology. The journal places particular emphasis on studies relating to defined effects of chemicals and mechanisms of toxicity, including toxic activities at the molecular level, in humans and experimental animals. Coverage includes new insights into analysis and toxicokinetics and into forensic toxicology. Review articles of general interest to toxicologists are an additional important feature of the journal.

Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:.

Arzneimittelforschung Drug Research is an international peer-reviewed journal presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Articles and experimental data from across the field of drug research address not only the issue of drug formulation, but also the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials. .